Managing Potential Side Effects of Semaglutide While semaglutide is generally well-tolerated, its important to be aware of potential side effects and how they might vary with compounded versions
Nothing contained on this site or in any communication should be considered a substitute for professional medical advice, diagnosis, or treatment
Conocidos comercialmente como Ozempic, Wegovy o Mounjaro, los GLP-1 imitan la accin de una hormona vinculada a la secrecin de insulina y a la sensacin de saciedad mediante mecanismos cerebrales

The following table describes GLP-1 receptor agonists, their dosing frequency and key pharmacokinetic parameters: Cautions and Contraindications Adverse Effects Acute pancreatitis (rare) Injection site reactions Gastrointestinal disturbances (nausea, vomiting, diarrhoea dehydration and possible renal impairment) Increase in pancreatic enzymes: lipase and amylase (dulaglutide, tirzepatide and semaglutide) Cholecystitis and cholelithiasis Delayed gastric emptying (semaglutide, exenatide, dulaglutide, tirzepatide (diminishes over time)) Increased heart rate Diabetic retinopathy complications (semaglutide, particularly in insulin-treated patients with known diabetic retinopathy) Interactions GLP-1 receptor agonists do not interact via cytochrome P450 , but delayed gastric emptying may alter drug absorption
Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease